King Pharma starts $1.6 bn bid for Alpharma

King Pharmaceuticals, Inc announced that it commenced a tender offer, through a wholly-owned subsidiary, to acquire all of the outstanding shares of Class A Common Stock of Alpharma Inc for $37 per share in cash.

The details can be read here.